TILE, EAT, and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 14, 2024. Jean-Jacques Guiony ...

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...

SAO PAULO (AP) — SAO PAULO (AP) — Despegar.com Corp. (DESP) on Thursday reported net income of $8.9 million in its third quarter. On a per-share basis, the Sao Paulo-based company said it had net ...

SAN JOSE, Calif. — SAN JOSE, Calif. — Firsthand Technology Value Fund Inc. (SVVC) on Thursday reported net income of $526,000 in its third quarter. On a per-share basis, the San Jose, California-based ...

Gambling.com (GAMB) delivered earnings and revenue surprises of 38.89% and 4.14%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

HOUSTON (AP) — HOUSTON (AP) — Salarius Pharmaceuticals, Inc. (SLRX) on Thursday reported a loss of $972,000 in its third quarter. The Houston-based company said it had a loss of 76 cents per share.

SALT LAKE CITY — SALT LAKE CITY — Security National Financial Corp. (SNFCA) on Thursday reported profit of $11.8 million in its third quarter. On a per-share basis, the Salt Lake City-based company ...

RENO, Nev. (AP) — RENO, Nev. (AP) — Aqua Metals Inc. (AQMS) on Thursday reported a loss of $5.2 million in its third quarter.

My Size, Inc. (MYSZ) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to loss of $3.52 per share a year ago. These figures are ...

Aqua Metals Inc. (AQMS) on Thursday reported a loss of $5.2 million in its third quarter. The Reno, Nevada-based company said it had a loss of 76 cents per share. In the final minutes of trading on ...

The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research ...

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share. The biotechnology company posted ...